BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38844554)

  • 1. Metabolism of alcohol ethoxylates (AEs) in rat, hamster, and human hepatocytes and liver S9: a pilot study for metabolic stability, metabolic pathway, and metabolites identification in vitro and in silico.
    Shi Q; Moors S; Dawick J; Kavanagh L; Neely T; Tian Y; Dreeßen B; Carrillo JC; Hein H; Boogaard PJ
    Arch Toxicol; 2024 Jun; ():. PubMed ID: 38844554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic in vitro metabolism of peptides; Comparison of human liver S9, hepatocytes and Upcyte hepatocytes with cyclosporine A, leuprorelin, desmopressin and cetrorelix as model compounds.
    Jyrkäs J; Tolonen A
    J Pharm Biomed Anal; 2021 Mar; 196():113921. PubMed ID: 33548873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and plasma protein binding of 16 straight- and branched-chain parabens in in vitro liver and skin models.
    Lester C; Hewitt NJ; Müller-Vieira U; Mayer M; Ellison C; Duplan H; Genies C; Jacques-Jamin C; Fabian E; Sorrell I; Lange D; Schepky A; Grégoire S
    Toxicol In Vitro; 2021 Apr; 72():105051. PubMed ID: 33188879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the Metabolites of Both Formononetin in Rat Hepatic S9 and Ononin in Rat Urine Samples and Preliminary Network Pharmacology Evaluation of Their Main Metabolites.
    Yang YZ; Wang T; Chen QL; Chen HB; He QS; Zhang YZ
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959870
    [No Abstract]   [Full Text] [Related]  

  • 5. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolism of [
    Nallani GC; ElNaggar SF; Shen L; Chandrasekaran A
    Regul Toxicol Pharmacol; 2017 Mar; 84():26-34. PubMed ID: 27993653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interspecies comparison of metabolism of two novel prototype PFAS.
    Licul-Kucera V; Ragnarsdóttir O; Frömel T; van Wezel AP; Knepper TP; Harrad S; Abou-Elwafa Abdallah M
    Chemosphere; 2024 Mar; 351():141237. PubMed ID: 38242512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the in vitro metabolic stability and metabolites of the anticancer derivative riccardin D-N in human and mouse hepatic S9 fractions using HPLC-Q-LIT-MS.
    Gao Y; Liu R; Gautam N; Ma B; Xie Z; Sun B; Zheng H; Liu D; Lou H
    J Pharm Biomed Anal; 2019 Sep; 174():734-743. PubMed ID: 31299454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metabolism of perospirone in rat, monkey and human liver microsomes.
    Mizuno Y; Tani N; Komuro S; Kanamaru H; Nakatsuka I
    Eur J Drug Metab Pharmacokinet; 2003; 28(1):59-65. PubMed ID: 14503666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrahepatic in vitro metabolism of peptides; comparison of human kidney and intestinal S9 fraction, human plasma and proximal tubule cells, using cyclosporine A, leuprorelin, and cetrorelix as model compounds.
    Jyrkäs J; Lassila T; Tolonen A
    J Pharm Biomed Anal; 2023 Feb; 225():115219. PubMed ID: 36630767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic metabolism of two alpha-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human.
    Wu WN; McKown LA; Kuo GH
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):271-6. PubMed ID: 17315538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro Metabolism of Sodium 9-dehydro-17-hydro-andrographolide-19-yl Sulfate in Rat Liver S9 by Liquid Chromatography-Mass Spectrometry Method.
    Zheng D; Shao J; Chen W; Luo Y
    Pharmacogn Mag; 2016 May; 12(Suppl 2):S102-8. PubMed ID: 27279693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biotransformation of the new antipsychotic agent, RWJ-46344 in rat hepatic S9 fraction: API-MS/MS/MS identification of metabolites.
    Wu WN; McKown LA; Moyer MD; Reitz AB
    J Pharm Biomed Anal; 2000 Dec; 24(2):307-16. PubMed ID: 11130209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of allocryptopine and protopine metabolites in rat liver S9 by high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Huang YJ; Xiao S; Sun ZL; Zeng JG; Liu YS; Liu ZY
    Rapid Commun Mass Spectrom; 2016 Jul; 30(13):1549-59. PubMed ID: 27321842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.
    Gandhi AS; Wohlfarth A; Zhu M; Pang S; Castaneto M; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2015 Mar; 7(3):187-98. PubMed ID: 24827428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vitro assays to investigate the hepatic metabolism of seven pesticides in Cyprinus carpio and Oncorhynchus mykiss.
    Tust M; Kohler M; Lagojda A; Lamshoeft M
    Chemosphere; 2021 Aug; 277():130254. PubMed ID: 34384174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of the new anxiolytic agent, RWJ-52763 in human hepatic S9 fraction-API-MS/MS identification of metabolites.
    Wu WN; McKown LA; Reitz AB
    J Pharm Biomed Anal; 2003 Feb; 31(1):95-102. PubMed ID: 12560053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley rats.
    Forkuo AD; Ansah C; Pearson D; Gertsch W; Cirello A; Amaral A; Spear J; Wright CW; Rynn C
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):84. PubMed ID: 29273084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.